Epithelial Tumors of the Thymus: Pathology, Biology, Treatment

Front Matter....Pages i-xi
Classification of Thymic Epithelial Neoplasms....Pages 1-8
Thymic Carcinoma....Pages 9-15
Thymoma/Thymic Carcinoma....Pages 17-21
A Clinicopathological Study of Thymomas in Singapore....Pages 23-28
Thymoma....Pages 29-34
 p53 -Alterations in Thymic Epithelial Tumors....Pages 35-40
p53 Protein Expression in Thymic Epithelial Tumors....Pages 41-45
p53 Overexpression and Thymoma Prognosis....Pages 47-54
Metallothionein Expression in Thymomas....Pages 55-56
Cytokeratin (CK) Profile in Thymomas....Pages 57-65
Neuroendocrine Differentiation in Thymic Epithelial Tumors....Pages 67-73
Microscopic Thymoma and Myasthenia Gravis....Pages 75-79
Complex and Differential Cytokeratin Profiles in Thymomas and Correlation with Normal Thymus....Pages 81-89
Unusual Recurrence of Mixed Thymoma in Breast....Pages 91-94
Histiocytosis -X of the Thymus....Pages 95-104
T Cell Development in the Human Thymus....Pages 105-109
Intrathymic Autoantigens and their Role in the Shaping of the Autoimmune T Lymphocyte Repertoire....Pages 111-118
T Cell Epitopes of the Acetylcholine Receptor and the Pathogenesis of Myasthenia Gravis....Pages 119-126
Thymus in Thymoma-Associated Myasthenia Gravis....Pages 127-133
Thymic Tumor Progression in SV40T Transgenic Mice Model....Pages 135-153
Analysis of a Murine Thymic Carcinogenesis Model Induced by the Expression of Large T of SV40....Pages 155-156
Inefficient Positive Selection of CD4+ T Cells in Epithelial Cell Tumors of the Human Thymus....Pages 157-164
Abnormal T Lymphocyte Development in Myasthenia Gravis-Associated Thymomas....Pages 165-177
Oligoclonal Peripheral T-Cell Lymphocytosis as a Result of Aberrant T-Cell Development in a Cortical Thymoma....Pages 179-185
Estrogens Modulate IL-6 Production by Cultured Normal and Pathological Human Thymic Epithelial Cells....Pages 187-194
Thymoma and Autoimmune Neurological Disorders....Pages 195-204
T-Cell Derived Mechanisms in the Pathogenesis of Myasthenia Gravis....Pages 205-212
Thymomas Express Ryanodine Receptor Epitopes....Pages 213-219
Titin Epitope in Thymoma....Pages 221-227
Accessory Molecule Expression in Human Thymomas and Thymus....Pages 229-234
CD40-Expression in Thymoma....Pages 235-245
Myasthenia Gravis with Thymoma and Fas Antigen....Pages 247-251
Myasthenia Gravis Patients have a Cellular Immune Response against Titin....Pages 253-260
Tumor Necrosis Factor Gene Polymorphisms in Thymoma and Non-Thymoma Myasthenia Gravis....Pages 261-264
Clinical Immunology of Thymic Tumors in Patients with Myasthenia Gravis....Pages 265-270
Myasthenia Gravis with Thymoma....Pages 271-280
Reproducibility of a Histogenetic Classification of Thymic Epithelial Tumours....Pages 281-287
Morphology of Thymic Remnants Removed after Video-Assisted Thoracoscopic Extended Thymectomy in Patients with Thymomatous Myasthenia Gravis....Pages 289-292
Core Needle Biopsy of Anterior Mediastinum Masses....Pages 293-298
Cyclin-Dependent Kinase 6 (PLSTIRE) Expression in Normal Thymus, Thymomas, and T-Cell Lymphoblastic Lymphoma....Pages 299-303
Our Approach in the Preparation for Thymectomy in Myasthenia Gravis....Pages 305-314
Onset of Myasthenia Gravis after Thymectomy for Thymoma....Pages 315-318
Aspects of Clinical Preparation of Thymectomy in Myasthenic Cases with or without Thymoma and the Clinico-Biological Follow-up of the Thymectomized Patients....Pages 319-327
Long-Term Prognosis of Patients with Thymoma-Associated Myasthenia Gravis....Pages 329-335
Thymoma and Myasthenia Gravis....Pages 337-341
Thymoma—Prognostic Factors and Outcome....Pages 343-350
Management of Thymectomised Myasthenic Patients....Pages 351-356
Management of Thymectomized Myasthenic Patients....Pages 357-364
Therapeutic Options in Locally Advanced Thymoma....Pages 365-370
The Role of Radiotherapy in Treatment of Thymoma....Pages 371-379
Back Matter....Pages 381-399